Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 147

1.

Differential ErbB1 signaling in squamous cell versus basal cell carcinoma of the skin.

Rittié L, Kansra S, Stoll SW, Li Y, Gudjonsson JE, Shao Y, Michael LE, Fisher GJ, Johnson TM, Elder JT.

Am J Pathol. 2007 Jun;170(6):2089-99.

PMID:
17525275
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Regulation of parathyroid hormone-related protein gene expression by epidermal growth factor-family ligands in primary human keratinocytes.

Cho YM, Lewis DA, Koltz PF, Richard V, Gocken TA, Rosol TJ, Konger RL, Spandau DF, Foley J.

J Endocrinol. 2004 Apr;181(1):179-90.

PMID:
15072578
[PubMed - indexed for MEDLINE]
Free Article
3.
4.

Lamin expression in normal human skin, actinic keratosis, squamous cell carcinoma and basal cell carcinoma.

Tilli CM, Ramaekers FC, Broers JL, Hutchison CJ, Neumann HA.

Br J Dermatol. 2003 Jan;148(1):102-9.

PMID:
12534602
[PubMed - indexed for MEDLINE]
5.

Decreased expression of thymidine phosphorylase/platelet-derived endothelial cell growth factor in basal cell carcinomas.

Stoebner PE, Le Gallic L, Berthe ML, Boulle N, Lallemant B, Marque M, Gaspard C, Delfour C, Lavabre-Bertrand T, Martinez J, Meunier L.

Exp Dermatol. 2008 Nov;17(11):908-15. doi: 10.1111/j.1600-0625.2008.00718.x. Epub 2008 Mar 12.

PMID:
18341568
[PubMed - indexed for MEDLINE]
6.

The expression of SnoN in normal human skin and cutaneous keratinous neoplasms.

Zhang X, Egawa K, Xie Y, Ihn H.

Int J Dermatol. 2009 Jun;48(6):579-83. doi: 10.1111/j.1365-4632.2009.03685.x.

PMID:
19538364
[PubMed - indexed for MEDLINE]
7.

Selective in situ protein expression profiles correlate with distinct phenotypes of basal cell carcinoma and squamous cell carcinoma of the skin.

Stelkovics E, Kiszner G, Meggyeshazi N, Korom I, Varga E, Nemeth I, Molnar J, Marczinovits I, Krenacs T.

Histol Histopathol. 2013 Jul;28(7):941-54. Epub 2013 Feb 28.

PMID:
23446646
[PubMed - indexed for MEDLINE]
8.

Significance of PC cell-derived growth factor and cyclin D1 expression in cutaneous squamous cell carcinoma.

Huang K, Huang C, Shan K, Chen J, Li H.

Clin Exp Dermatol. 2012 Jun;37(4):411-7. doi: 10.1111/j.1365-2230.2011.04275.x. Epub 2012 Mar 15.

PMID:
22420613
[PubMed - indexed for MEDLINE]
9.
10.

Amphiregulin regulates the activation of ERK and Akt through epidermal growth factor receptor and HER3 signals involved in the progression of pancreatic cancer.

Yotsumoto F, Fukami T, Yagi H, Funakoshi A, Yoshizato T, Kuroki M, Miyamoto S.

Cancer Sci. 2010 Nov;101(11):2351-60. doi: 10.1111/j.1349-7006.2010.01671.x.

PMID:
20726858
[PubMed - indexed for MEDLINE]
11.

Activation of the PI3K/AKT signalling pathway in non-melanoma skin cancer is not mediated by oncogenic PIK3CA and AKT1 hotspot mutations.

Hafner C, Landthaler M, Vogt T.

Exp Dermatol. 2010 Aug;19(8):e222-7. doi: 10.1111/j.1600-0625.2009.01056.x.

PMID:
20557351
[PubMed - indexed for MEDLINE]
Free Article
12.

Expression of epiregulin, a novel epidermal growth factor ligand associated with prognosis in human oral squamous cell carcinomas.

Shigeishi H, Higashikawa K, Hiraoka M, Fujimoto S, Mitani Y, Ohta K, Takechi M, Kamata N.

Oncol Rep. 2008 Jun;19(6):1557-64.

PMID:
18497965
[PubMed - indexed for MEDLINE]
13.

Insulin-like growth factor-binding protein-7 (IGFBP7) transcript: A-to-I editing events in normal and cancerous human keratinocytes.

Hochberg M, Gilead L, Markel G, Nemlich Y, Feiler Y, Enk CD, Denichenko P, Karni R, Ingber A.

Arch Dermatol Res. 2013 Aug;305(6):519-28. doi: 10.1007/s00403-013-1338-5. Epub 2013 Mar 30.

PMID:
23543219
[PubMed - indexed for MEDLINE]
14.

Overexpression of phosphorylated-STAT3 correlated with the invasion and metastasis of cutaneous squamous cell carcinoma.

Suiqing C, Min Z, Lirong C.

J Dermatol. 2005 May;32(5):354-60.

PMID:
16043897
[PubMed - indexed for MEDLINE]
15.

Matrix metalloproteinase-7 activates heparin-binding epidermal growth factor-like growth factor in cutaneous squamous cell carcinoma.

Kivisaari AK, Kallajoki M, Ala-aho R, McGrath JA, Bauer JW, Königová R, Medvecz M, Beckert W, Grénman R, Kähäri VM.

Br J Dermatol. 2010 Oct;163(4):726-35. doi: 10.1111/j.1365-2133.2010.09924.x. Epub 2010 Sep 2.

PMID:
20586780
[PubMed - indexed for MEDLINE]
16.

Expression of EGF receptor, involucrin, and cytokeratins in basal cell carcinomas and squamous cell carcinomas of the skin.

Lavrijsen AP, Tieben LM, Ponec M, van der Schroeff JG, van Muijen GN.

Arch Dermatol Res. 1989;281(2):83-8.

PMID:
2476080
[PubMed - indexed for MEDLINE]
17.

Expression of RPE65, a putative receptor for plasma retinol-binding protein, in nonmelanocytic skin tumours.

Hinterhuber G, Cauza K, Dingelmaier-Hovorka R, Diem E, Horvat R, Wolff K, Foedinger D.

Br J Dermatol. 2005 Oct;153(4):785-9.

PMID:
16181461
[PubMed - indexed for MEDLINE]
18.

Mutation spectra of epidermal p53 clones adjacent to basal cell carcinoma and squamous cell carcinoma.

Bäckvall H, Strömberg S, Gustafsson A, Asplund A, Sivertsson A, Lundeberg J, Ponten F.

Exp Dermatol. 2004 Oct;13(10):643-50.

PMID:
15447725
[PubMed - indexed for MEDLINE]
19.

Proteinase-activated receptor-2 expression in basal and squamous cell carcinomas compared with normal skin.

Dastgheib L, Monabati A, Mohammadian A, Sari-Aslani F, Marzban S, Namazi MR.

J Cutan Pathol. 2009 Mar;36(3):314-7. doi: 10.1111/j.1600-0560.2008.01018.x. Epub 2008 Nov 19.

PMID:
19032384
[PubMed - indexed for MEDLINE]
20.

Activation of epidermal growth factor receptor signaling by the prostaglandin E(2) receptor EP4 pathway during gastric tumorigenesis.

Oshima H, Popivanova BK, Oguma K, Kong D, Ishikawa TO, Oshima M.

Cancer Sci. 2011 Apr;102(4):713-9. doi: 10.1111/j.1349-7006.2011.01847.x. Epub 2011 Feb 2.

PMID:
21205091
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk